Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
321
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
+2.32M
-
Total reported value, excl. options
-
$4.96B
-
Value change
-
+$72M
-
Put/Call ratio
-
0.66
-
Number of buys
-
157
-
Number of sells
-
-170
-
Price
-
$39.89
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q2 2021
417 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q2 2021.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 321 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
of 159M outstanding shares and own 78.45% of the company stock.
Largest 10 shareholders include FMR LLC (21.1M shares), VANGUARD GROUP INC (12.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.3M shares), Bellevue Group AG (9.93M shares), ARK Investment Management LLC (8.91M shares), BlackRock Inc. (8.18M shares), Clearbridge Investments, LLC (6.82M shares), STATE STREET CORP (3.23M shares), JPMORGAN CHASE & CO (2.28M shares), and Camber Capital Management LP (2M shares).
This table shows the top 321 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.